Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19—A Theory of Autoimmunity Against ACE-2 Explained
Philip McMillan, Thomas Dexhiemer, Richard R. Neubig, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Current and Emerging Knowledge in COVID-19
Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, et al.
Radiology (2023) Vol. 306, Iss. 2
Open Access | Times Cited: 72
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Yannick Galipeau, Curtis Cooper, Marc‐André Langlois
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Persistent SARS-2 infections contribute to long COVID-19
John J. L. Jacobs
Medical Hypotheses (2021) Vol. 149, pp. 110538-110538
Open Access | Times Cited: 92
Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, et al.
Clinical Science (2021) Vol. 135, Iss. 15, pp. 1805-1824
Open Access | Times Cited: 59
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2
Eli Magen, Avi Yakov, Ilan Green, et al.
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 1, pp. 30-36
Open Access | Times Cited: 47
COVID-19 Vaccines: Current and Future Perspectives
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 24
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
Anthony J. Turner, Natalia N. Nalivaeva
Peptides (2022) Vol. 151, pp. 170766-170766
Open Access | Times Cited: 31
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
Carmen M. Labandeira, María A. Pedrosa, Aloia Quijano, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
Weihang He, Xiaoqiang Liu, Bing Hu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS‐CoV‐2 infection
Yannick Galipeau, Nicolas Castonguay, Pauline S. McCluskie, et al.
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access
The impact of COVID-19 on autoimmune diseases
Altijana Hromić-Jahjefendić, Abas Sezer, Irma Mahmuljin
Progress in molecular biology and translational science (2025)
Closed Access
Otitis Media Practice During the COVID-19 Pandemic
Tal Marom, Jacob Pitaro, Udayan K. Shah, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 25
COVID-19 disease and autoimmune disorders: A mutual pathway
Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy
World Journal of Methodology (2022) Vol. 12, Iss. 4, pp. 200-223
Open Access | Times Cited: 24
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy
Antonio Merolli, Leila Kasaei, Santhamani Ramasamy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Discriminating promiscuous from target‐specific autoantibodies in COVID‐19
Mikhail Lebedin, Clara Vázquez García, Lisa Spatt, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 5
Open Access | Times Cited: 14
Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2
Yen‐Chung Lai, Yuwei Cheng, Chiao-Hsuan Chao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
José L. Labandeira‐García, Carmen M. Labandeira, Rita Valenzuela, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 502-502
Open Access | Times Cited: 17
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
Denis Kolesov, Maria V. Sinegubova, Lutsia K. Dayanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 393-393
Open Access | Times Cited: 16
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
Maria Giovanna Danieli, Mario Andrea Piga, Alberto Paladini, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 5
Open Access | Times Cited: 21
Diabetes, COVID‐19, and questions unsolved
F. D'Souza, Raffaella Buzzetti, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 5
Open Access | Times Cited: 8
Autoimmune encephalitis in COVID-19 patients: a systematic review of case reports and case series
Xue Hua, Li Zeng, Hongxian He, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Mechanisms of Gut-Related Viral Persistence in Long Covid
Philip McMillan, Anthony J. Turner, Bruce D. Uhal
(2024)
Open Access | Times Cited: 2
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
María A. Pedrosa, Carmen M. Labandeira, Rita Valenzuela, et al.
Brain Behavior and Immunity (2022) Vol. 108, pp. 255-268
Open Access | Times Cited: 13
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
Jean Amiral, Jerard Seghatchian
Transfusion and Apheresis Science (2022) Vol. 62, Iss. 1, pp. 103625-103625
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top